NEW BRUNSWICK, N.J.,
Jan. 3, 2018 /PRNewswire/
-- Nominations are now being accepted for the 2018 Dr.
Paul Janssen Award for Biomedical
Research. This prestigious award celebrates today's most dedicated
researchers and champions of science whose basic or clinical
discoveries have made, or have the potential to make, significant
contributions toward improving human health. Nominations will be
accepted until February 28, 2018 at
www.pauljanssenaward.com for consideration by an independent
selection committee of world-renowned scientists. A $200,000 cash prize will be awarded to the
scientist or group of scientists receiving the Award.
The Dr. Paul Janssen Award for
Biomedical Research honors Dr. Paul
Janssen (1926-2003), one of the most productive
pharmaceutical scientists of the 20th century, who was responsible
for breakthrough treatments in key disease areas including pain
management, psychiatry, infectious disease and gastroenterology.
Janssen founded Janssen Pharmaceutica, N.V., now part of the
Johnson & Johnson Family of Companies (NYSE: JNJ).
"Behind every discovery that holds the promise for saving and
improving lives are the scientists who pursue a vision and work
tirelessly for many years to make it all possible," said
Paul Stoffels, M.D., Chief
Scientific Officer, Johnson & Johnson. "We are proud to honor
the legacy of Dr. Paul by recognizing the outstanding researchers
and champions of science who make a lasting impact on our
world."
In 2017, the Dr. Paul Janssen
Award recognized trailblazing scientist Douglas Wallace, Ph.D., of the Children's
Hospital of Philadelphia, for
pioneering the field of mitochondrial genetics and its application
to the study of disease, aging, and patterns of human
migration.
"Scientific research is crucial to advancing our understanding
of the mechanisms underlying human health and disease," said
David Julius, Ph.D., Professor and
Chair of the Department of Physiology at the University of California, San Francisco, and Chair
of the 2018 Dr. Paul Janssen Award
selection committee. "The selection committee encourages
nominations of scientists from academia, industry, government and
scientific institutions around the world who champion science
through the work they do everyday and exemplify the leadership and
passion of Dr. Paul."
Previous Award winners include:
- 2017 – Douglas Wallace, Ph.D.
- 2016 – Yoshinori Ohsumi, Ph.D.,
Nobel Laureate
- 2015 – Bert Vogelstein,
M.D.
- 2014 – Emmanuelle Charpentier,
Ph.D. and Jennifer Doudna,
Ph.D.
- 2013 – David Julius, Ph.D.
- 2012 – Victor Ambros, Ph.D., and
Gary Ruvkun, Ph.D.
- 2011 – Napoleone Ferrara,
M.D.
- 2010 – Anthony S. Fauci, M.D.
and Erik De Clercq, M.D.,
Ph.D.,
- 2009– Axel Ullrich, Ph.D.
- 2008 – Professor Marc Feldmann,
FMedSci, FAA, FRS, Emeritus Professor and Sir Ravinder Maini, FRCP, FMedSci, FRS
- 2006 – Craig Mello, Ph.D., Nobel
Laureate
To learn more about past Dr. Paul
Janssen Award winners, visit www.pauljanssenaward.com.
The 2018 Dr. Paul Janssen Award
winner will be announced in spring 2018.
About The Dr. Paul Janssen
Award for Biomedical Research
Established by Johnson &
Johnson, The Dr. Paul Janssen Award
salutes champions of science and the most passionate and creative
scientists in basic or clinical research whose scientific
achievements have made, or have strong potential to make, a
measurable impact on human health. The Award is named after the
scientist who founded Janssen Pharmaceutica, N.V. in 1953. Known to
his colleagues as "Dr. Paul," Janssen helped save millions of lives
through his contribution to the discovery and development of more
than 80 medicines, four of which remain on the World Health
Organization's list of essential medicines. In 1961, Janssen
Pharmaceutica, N.V. joined the Johnson & Johnson Family of
Companies. Janssen's legacy continues to inspire Johnson &
Johnson and its commitment to finding innovative cures for unmet
medical needs. Visit www.pauljanssenaward.com for more
information.
About Johnson & Johnson
Caring for the world, one
person at a time, inspires and unites the people of
Johnson & Johnson. We embrace research and science -
bringing innovative ideas, products and services to advance the
health and well-being of people. Our approximately
132,500 employees at more than 250 Johnson & Johnson
operating companies work with partners in health care to touch the
lives of over a billion people every day, throughout the world.
View original content with
multimedia:http://www.prnewswire.com/news-releases/dr-paul-janssen-award-for-biomedical-research-issues-2018-call-for-nominations-to-celebrate-champions-of-science-300577115.html
SOURCE Johnson & Johnson